This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group's key programs.
Standard submission dates apply for all listings, unless otherwise noted.
Guidance For Investigators Planning to Submit a Program Project Grant (P01)
Notice: Internet links not permitted in NIH Grant Applications
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
| Title | Announcement # | Expiration Date | Activity Code | Contact |
|---|---|---|---|---|
| Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems | PAR-20-155 (R01 Clinical Trial Optional) | 09/08/2022 | R01 | Richard Mazurchuk, Ph.D. |
| Administrative Supplement for Research on Dietary Supplements | PA-20-227 (Admin Supp-Clinical Trial Not Allowed) | 04/16/2023 | Sharon Ross, Ph.D., M.P.H. | |
| Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) | PAR-22-114 | 01/24/2025 | ||
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-20-313 (UH2/UH3 Clinical Trial Not Allowed) | 10/11/2023 | ||
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-20-314 (UH3 Clinical Trials Not Allowed) | 10/11/2023 | ||
| Basic Research in Cancer Health Disparities | PAR-21-323 (R21 Clinical Trial Not Allowed) | 09/08/2024 | ||
| Basic Research in Cancer Health Disparities | PAR-21-324 (R03 Clinical Trial Not Allowed) | 09/08/2024 | ||
| Basic Research in Cancer Health Disparities | PAR-21-322 (R01 Clinical Trial Not Allowed) | 09/08/2024 | ||
| Cancer Prevention and Control Clinical Trials Grant Program | PAR-21-035 (R01 Clinical Trial Required) | 01/08/2024 | ||
| Cancer Prevention and Control Clinical Trials Planning Grant Program | PAR-22-173 (R34 Clinical Trials Optional) | 05/08/2025 | ||
| Cancer Prevention and Control Clinical Trials Planning Grant Program | PAR-22-174 (U34 Clinical Trials Optional) | 05/08/2025 | ||
| Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research | PAR-22-099 (R01 Clinical Trial Optional) | 05/08/2025 | ||
| Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies | PAR-21-329 (R01 Clinical Trial Optional) | 11/06/2024 | ||
| Co-infection and Cancer | PAR-20-062 (R01 Clinical Trial Not Allowed) | 01/08/2023 | ||
| Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome | RFA-TR-22-011 (R21 Clinical Trial Not Allowed) | 05/23/2023 | ||
| Emergency Awards: HEAL Initiative- New Innovator Award | RFA-TR-22-013 (DP2 Clinical Trial Not Allowed) | 05/23/2023 | ||
| HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells | RFA-NS-22-018 (U19 Clinical Trial Not Allowed) | 03/10/2023 | ||
| HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment | RFA-NS-22-034 (R01 Clinical Trial Not Allowed) | 12/07/2024 | ||
| HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) | RFA-NS-22-050 | 02/24/2023 | ||
| HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center | RFA-NS-22-021 (U24 Clinical Trial Not Allowed) | 10/12/2022 | ||
| Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity | PAR-22-092 (R01 - Clinical Trials Optional) | 09/08/2024 | ||
| Mechanisms that Impact Cancer Risk after Bariatric Surgery | PAR-21-332 (R21 Clinical Trial Not Allowed) | 09/08/2024 | ||
| Mechanisms that Impact Cancer Risk after Bariatric Surgery | PAR-21-331 (R01 Clinical Trial Optional) | 09/08/2024 | ||
| Music and Health: Understanding And Developing Music Medicine | PAR-21-100 (R01 Clinical Trial Optional) | 02/06/2023 | ||
| Music and Health: Understanding And Developing Music Medicine | PAR-21-099 (R21 Clinical Trial Optional) | 02/17/2023 | ||
| NCI Clinical and Translational Exploratory/Developmental Studies | PAR-20-292 (R21 Clinical Trial Optional) | 07/21/2022 | ||
| NIH Research Project Grant | PA-20-185 (Parent R01 Clinical Trial Not Allowed) | 05/08/2023 | ||
| Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection | NOT-CA-20-067 (R01 Clinical Trial Not Allowed) | 01/08/2023 | ||
| Notice of Correction to PAR-21-035, Cancer Prevention and Control Clinical Trials Grant Program | NOT-CA-22-012 (R01 Clinical Trials Required) | 01/08/2024 | ||
| Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention and Control Clinical Trials Planning Grant | NOT-CA-22-062 (U34 Clinical Trials Optional) | 07/15/2022 | ||
| Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention and Control Clinical Trials Planning Grant Program | NOT-CA-22-061 (R34 Clinical Trials Optional) | 07/15/2022 | ||
| Notice of NCI Participation in PAR-22-064, Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities | NOT-CA-22-048 (R01 Clinical Trial Optional) | 01/08/2025 | ||
| Notice of Special Interest: Advancing the Science of Geriatric Palliative Care | NOT-AG-20-041 | 09/08/2023 | ||
| Notice of Special Interest: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications | NOT-DK-20-001 | 01/08/2023 | ||
| Notice of Special Interest: National Cancer Institute Administrative Supplement Opportunity for Strategies to Optimize Recruitment and Retention of Cancer Prevention and Symptom Management Clinical Trial Participants | NOT-CA-21-070 | 05/16/2023 | ||
| Notice of Special Interest (NOSI): Biology of Lung and Head and Neck Preneoplasia | NOT-CA-21-057 | 05/08/2023 | ||
| Notice of Special Interest (NOSI): Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults | NOT-CA-21-108 | 05/08/2023 | ||
| Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity | NOT-CA-22-001 | 11/06/2024 | ||
| Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers | NOT-CA-21-028 | 01/08/2024 | ||
| Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions | NOT-CA-20-044 | 05/08/2023 | ||
| Notice of Special Interest: Small Business Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones | NOT-DK-20-002 | 01/08/2023 | ||
| Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | NOT-NS-20-107 | 05/16/2024 | ||
| Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit | PAR-21-335 (U24 Clinical Trial Not Allowed) | 06/12/2024 | ||
| Pancreatic Cancer Detection Consortium: Research Units | PAR-21-334 (U01 Clinical Trial Optional) | 06/12/2024 | ||
| Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities | PAR-22-064 (R01 Clinical Trial Optional) | 01/08/2025 | ||
| Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection | PAR-20-053 (R01 Clinical Trial Not Allowed) | 01/08/2023 | ||
| Promoting Research on Music and Health: Phased Innovation Award for Music Interventions | PAR-20-266 (R61/R33 Clinical Trial Optional) | 06/20/2023 | ||
| Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants | PAR-20-074 (R01 Clinical Trial Not Allowed) | 10/29/2022 | ||
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes | PAR-20-276 (R01 Clinical Trial Not Allowed) | 09/08/2022 | ||
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes | PAR-20-277 (R21 Clinical Trials Not Allowed) | 09/08/2022 | ||
| Stephen I. Katz Early Stage Investigator Research Project Grant | PAR-21-038 (R01 Clinical Trial Not Allowed) | 12/29/2023 | ||
| Stephen I. Katz Early Stage Investigator Research Project Grant | PAR-21-039 (R01 Basic Experimental Studies with Humans Required) | 12/29/2023 | ||
| Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research | PAR-21-330 (U01 Clinical Trial Not Allowed) | 10/12/2024 |